Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013
What this trial is testing

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Who this might be right for
Bladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more
Cancer Research UK 81
Not applicableWithdrawnNCT05287347
What this trial is testing

Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

Who this might be right for
Pancreatic Adenocarcinoma
Beth Israel Deaconess Medical Center
Early research (Phase 1)Not Yet RecruitingNCT07796997
What this trial is testing

GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaDuodenal Cancer+1 more
University of Illinois at Chicago 20
Testing effectiveness (Phase 2)Study completedNCT00033384
What this trial is testing

CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT00075647
What this trial is testing

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT03214250
What this trial is testing

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Parker Institute for Cancer Immunotherapy 129
Testing effectiveness (Phase 2)WithdrawnNCT06398587
What this trial is testing

Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+3 more
OHSU Knight Cancer Institute
Large-scale testing (Phase 3)Ended earlyNCT00031837
What this trial is testing

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerThromboembolism
Gary Morrow 400
Early research (Phase 1)Ended earlyNCT06076837
What this trial is testing

The Seven Trial: Exploiting the Unfolded Protein Response

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Adenocarcinoma Metastatic
HonorHealth Research Institute 6
Very early researchStudy completedNCT01821612
What this trial is testing

Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Alliance for Clinical Trials in Oncology 23
Not applicableUnknownNCT05955092
What this trial is testing

Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02077881
What this trial is testing

Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaMetastatic Pancreatic Cancer
NewLink Genetics Corporation 157
Testing effectiveness (Phase 2)UnknownNCT01021800
What this trial is testing

Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma

Who this might be right for
Pancreatic Tubular Adenocarcinoma
Blood Transfusion Centre of Slovenia 30
Testing effectiveness (Phase 2)Study completedNCT00365144
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
University of California, San Francisco 36
Early research (Phase 1)Ended earlyNCT03323944
What this trial is testing

CAR T Cell Immunotherapy for Pancreatic Cancer

Who this might be right for
Pancreatic CancerCancer of the Pancreas
University of Pennsylvania 54
Testing effectiveness (Phase 2)Looking for participantsNCT06387342
What this trial is testing

Namodenoson Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Cancer
Can-Fite BioPharma 20
Not applicableStudy completedNCT02680990
What this trial is testing

Resilience and Exercise in Advanced Cancer Treatment

Who this might be right for
Pancreatic AdenocarcinomaGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal Junction
Milton S. Hershey Medical Center 14
Testing effectiveness (Phase 2)Temporarily pausedNCT04111172
What this trial is testing

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal AdenocarcinomaGastric Adenocarcinoma+35 more
Thomas Jefferson University 48
Early research (Phase 1)Study completedNCT01764477
What this trial is testing

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Prism Pharma Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT07214298
What this trial is testing

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Roswell Park Cancer Institute 35
Next Page